Environmental Care

2050 Objectives

Reducing our CO2 footprint, downsizing energy consumption and limiting our waste is a core part of our sustainability commitment and initiatives.

In 2020, we reviewed and revised our environmental goals to reflect the longer-term greenhouse gas reduction requirement to meet the Paris Climate Agreement. The Paris Climate Agreement sets out a global climate action plan to limit global warming to well below 2°C and is pursuing efforts to limit it to 1.5°C.

As an affiliate of the Ajinomoto group, Ajinomoto Bio-Pharma Services’ climate objectives are included in the SBTi group targets.

With our energy and greenhouse gas targets, we aim to reduce our CO2 emissions intensity to below 50% in 2030 (Scope baseline year 2019) and to become carbon neutral in 2050.

FY2019 FY2022 FY2030 FY2050
Reduce energy consumption and promote production of climate neutral energy Greenhouse Gases Total amount of Scope 1 and Scope 2 Reference year of carbon footprint


15% reduction 50% reduction Carbon neutral
Scope 3 Reference year of carbon footprint 8% reduction 24% reduction
Renewable Energy Power Ratio   Start of RE100 10% 50% 100%